Crinetics Pharmaceuticals Stock (NASDAQ: CRNX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 939.46K |
Day Range | - - - |
52 Wk Range | 15.76 - 55.77 |
Market Cap | $4.15B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 7.6% |
Days to Cover | 4.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) through any online brokerage.
Other companies in Crinetics Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA) and Ultragenyx Pharmaceutical (NASDAQ:RARE).
There is no analysis for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals has a consensus price target of $63.31.
The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $52.66 last updated July 19, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.